About Electrochemical Biosensors
Electrochemical biosensors are a type of biosensor that utilizes electrochemical transduction to convert a biological recognition event into a measurable electrical signal. They are analytical devices that consist of a biological recognition element, such as an enzyme, antibody, or whole cell, immobilized on a transducer, typically an electrode. The electrochemical biosensors market is expected to witness positive growth driven by rising demand for POC diagnostics, technological advancements, and diverse applications.
Attributes | Details |
---|
Study Period | 2018-2030 |
Base Year | 2023 |
Unit | Value (USD Million) |
The market is seeing moderate market players, by seeing huge growth in this market the key leading vendors are highly focusing on production technologies, efficiency enhancement, and product life. This market has various growth opportunities that leading players capture via tracking the ongoing process enhancement and huge investment in market growth strategies. Analyst at AMA Research estimates that Global Players will contribute the maximum growth to Global Electrochemical Biosensors market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.
Abbott (United States), Thermo Fisher Scientific Inc. (United States), F. Hoffmann-La Roche Ltd. (Switzerland), Siemens Healthineers AG (Germany), Johnson & Johnson Services, Inc. (United States), Medtronic (Ireland), Bio-Rad Laboratories, Inc. (United States), Qiagen (Germany), Merck KGaA (Germany) and Randox Laboratories Ltd. (United Kingdom) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Sysmex Corporation (Japan), Beckman Coulter, Inc. (United States), Horiba, Ltd. (Japan), Zydus Group (India) and MESO SCALE DIAGNOSTICS, LLC. (United States).
Segmentation Overview
AMA Research has segmented the market of Global Electrochemical Biosensors market by Type (Diagnosis and Monitoring), Application (Point-of-Care Testing, Environmental Monitoring, Food Safety and Others) and Region.
On the basis of geography, the market of Electrochemical Biosensors has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Technology, the sub-segment i.e. Amperometric will boost the Electrochemical Biosensors market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End User, the sub-segment i.e. Healthcare will boost the Electrochemical Biosensors market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Influencing Trend:
Growing Demand in Healthcare
Market Growth Drivers:
The Global Population is Aging, Growing Awareness of Personalized Medicine and The Increasing Prevalence of Chronic Diseases
Challenges:
Competition from Alternative Technologies
Restraints:
Limited Sensitivity and Specificity
Opportunities:
Increasing Demand for Rapid and Point-of-Care Diagnostics and Integration with Artificial Intelligence
Market Leaders and their expansionary development strategies
In February 2023, Abbott Laboratories announced the acquisition of Tactiq Biosystems, a company specializing in the development and manufacturing of microfluidic biosensors, for an undisclosed amount. This merger aims to strengthen Abbott's point-of-care diagnostic offerings by incorporating Tactiq's microfluidic technology.
In February 2023, Dexcom launched the G7 sensor in the United States. The G7 is a continuous glucose monitoring (CGM) sensor that is designed to be worn for up to 14 days. It is smaller and lighter than previous versions, and it features a Bluetooth connection that allows users to transmit their glucose data to a smartphone or other device.
Key Target Audience
Government Authorities, Research Center, Regulatory Bodies, Potential Investors, Marketing and Consultancy Firms and Others
About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.
Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.
The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.